January 17，Deputy Secretary of the Party Committee of Shaanxi Pharmaceutical Group、General Manager Li Yuan and his delegation went to Bank of Beijing Xi’an Branch for exchange and discussion。GroupChief Accountant Lei Yongquan、General Manager Assistant Tong Zhuobin，And Group Finance Department、Financial person in charge of Paion Pharmaceuticals, Main leaders of the management team of Bank of Beijing Xi’an Branch、The heads of relevant departments and business docking branches participated in the discussion。

Secretary of the Party Committee of Bank of Beijing Xi’an Branch、President Shen Jianfeng first expressed his warm welcome to the arrival of Li Yuan and his party，And introduced the operation situation of Bank of Beijing Xi’an Branch in recent years，And a brief explanation of the business development with Shaanxi Pharmaceutical Group。

Deputy Secretary of the Group Party Committee、General Manager Li Yuan introduced the overall operating situation and group strategic thinking of Shaanxi Pharmaceutical Group，HighlightedConstruction of the biomedical industrial park of “R&D pipeline + R&D base + national laboratory + industry”、Construction of Traditional Chinese Medicine Industrial Park，And smart medical care、Pharmaceutical e-commerce、Project construction status in the fields of new retail of medicines and specialty health foods。Chief Accountant Lei Yongquan briefly introduced the group’s financial operations and the overall ideas for investment and financing in the next step，And expressed his gratitude to Bank of Beijing for its continuous support to the group’s subsidiaries。

After communication，Both parties agree，We need to further increase the depth and breadth of cooperation，My stake betting appBank Stake Sports Bettingof Beijing will focus on the construction of Shaanxi Pharmaceutical Group Industrial Park project、Pharmaceutical e-commerce online financing and pharmaceutical supply chain financing and other fields，Provide efficient and fast comprehensive financial service solutions for the group，Fully support the rapid transformation and development of Shaanxi Pharmaceutical Group。